![]() |
|||
A2103-200 | Biovision | 200 µg | EUR 480 |
![]() |
|||
abx060650-1mg | Abbexa | 1 mg | EUR 1692 |
![]() |
|||
abx060652-1mg | Abbexa | 1 mg | EUR 1873 |
![]() |
|||
abx060653-1mg | Abbexa | 1 mg | EUR 1692 |
![]() |
|||
abx060654-1mg | Abbexa | 1 mg | EUR 1692 |
![]() |
|||
abx060655-1mg | Abbexa | 1 mg | EUR 1692 |
![]() |
|||
STJ400091 | St John's Laboratory | 1 mg | EUR 446 |
Description: Human coronavirus OC43 (hCoV-OC43) is an enveloped, positive-stranded RNA virus. HCoV-OC43 causes a significant fraction of upper respiratory tract infections, especially common colds. |
![]() |
|||
STJ400092 | St John's Laboratory | 1 mg | EUR 446 |
Description: Human coronavirus OC43 (hCoV-OC43) is an enveloped, positive-stranded RNA virus. HCoV-OC43 causes a significant fraction of upper respiratory tract infections, especially common colds. |
![]() |
|||
A2061-50 | Biovision | 50 µg | EUR 480 |
![]() |
|||
P1509-10 | Biovision | 10µg | EUR 551 |
![]() |
|||
AR12-MA0010 | Abfrontier | 100 ul | EUR 334 |
Description: Mouse monoclonal to MERS-CoV NP |
![]() |
|||
AR12-MA0011 | Abfrontier | 100 ul | EUR 334 |
Description: Mouse monoclonal to MERS-CoV NP |
![]() |
|||
abx023139-100ug | Abbexa | 100 ug | EUR 857 |
![]() |
|||
abx023143-100ug | Abbexa | 100 ug | EUR 857 |
![]() |
|||
PCR-H731-48R | Bioingentech | 48T | EUR 823 |
![]() |
|||
PCR-H731-96R | Bioingentech | 96T | EUR 1113 |
![]() |
|||
E4901-100 | Biovision | 100 assays | EUR 753 |
![]() |
|||
P1506-10 | Biovision | 10µg | EUR 156 |
![]() |
|||
P1506-50 | Biovision | 50µg | EUR 551 |
![]() |
|||
P1507-10 | Biovision | 10µg | EUR 156 |
![]() |
|||
P1507-50 | Biovision | 50µg | EUR 551 |
![]() |
|||
P1523-10 | Biovision | 10 µg | EUR 156 |
![]() |
|||
P1523-50 | Biovision | 50 µg | EUR 551 |
![]() |
|||
P1534-10 | Biovision | 10 µg | EUR 156 |
![]() |
|||
P1534-50 | Biovision | 50 µg | EUR 551 |
![]() |
|||
abx060656-1mg | Abbexa | 1 mg | EUR 1692 |
![]() |
|||
VAng-Wyb8616-inquire | Creative Biolabs | inquire | Ask for price |
Description: SARS-CoV E Protein ( 34.7 kDa), recombinant protein from E. coli, 1 mg/mL. |
![]() |
|||
STJ140102 | St John's Laboratory | 150 µg | EUR 231 |
Description: Goat polyclonal to Spike protein of Middle East respiratory Syndrome coronavirus. Coronaviruses access host cells by membrane fusion, a process mediated by specific fusion or “spike” proteins on the virion, often activated by cellular proteases. |
![]() |
|||
RTq-H731-100R | Bioingentech | 100T | EUR 1311 |
![]() |
|||
RTq-H731-150R | Bioingentech | 150T | EUR 1787 |
![]() |
|||
RTq-H731-50R | Bioingentech | 50T | EUR 963 |
![]() |
|||
DEIA2020 | Creative Diagnostics | 96 tests | EUR 905 |
Description: SARS-CoV-2 Antigen ELISA Kit intended use is for quantitative detection of the recombinant SARS-COV-2 nucleoprotein antigen in human serum. The use of this kit for natural samples need to be validated by the end user due to the complexity of natural targets and unpredictable interference. |
![]() |
|||
A2060-50 | Biovision | 50 µg | EUR 480 |
![]() |
|||
A2064-100 | Biovision | 100 µg | EUR 318 |
![]() |
|||
A2065-100 | Biovision | 100 µg | EUR 318 |
![]() |
|||
A2066-100 | Biovision | 100 µg | EUR 318 |
![]() |
|||
A3000-50 | Biovision | 50 µg | EUR 419 |
![]() |
|||
P1508-10 | Biovision | 10µg | EUR 156 |
![]() |
|||
P1508-50 | Biovision | 50µg | EUR 551 |
![]() |
|||
P1510-10 | Biovision | 10µg | EUR 156 |
![]() |
|||
P1510-50 | Biovision | 50µg | EUR 551 |
![]() |
|||
P1512-10 | Biovision | 10µg | EUR 257 |
![]() |
|||
P1519-10 | Biovision | 10µg | EUR 156 |
![]() |
|||
P1519-50 | Biovision | 50µg | EUR 551 |
![]() |
|||
P1537-10 | Biovision | 10 µg | EUR 156 |
![]() |
|||
P1537-50 | Biovision | 50 µg | EUR 530 |
![]() |
|||
P1539-10 | Biovision | 10 µg | EUR 156 |
![]() |
|||
P1539-50 | Biovision | 50 µg | EUR 530 |
![]() |
|||
P1550-10 | Biovision | 10 μg | EUR 156 |
![]() |
|||
P1550-50 | Biovision | 50 μg | EUR 551 |
![]() |
|||
P1551-10 | Biovision | 10 μg | EUR 156 |
![]() |
|||
P1551-50 | Biovision | 50 μg | EUR 551 |
![]() |
|||
K1460-100 | Biovision | 100 Rxns | Ask for price |
![]() |
|||
CoV2Ag-1 | UnScience | 1T | EUR 8 |
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again. |
![]() |
|||
9901-NCOV-03G | Roche Diagnostics | 25 Tests/Kit | EUR 94 |
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
![]() |
|||
K1460 | Biovision | 100 Rxns | EUR 570 |
Description: Kit for detection of SARS-CoV-2 in respiratory specimens using Real-Time (RT-PCR). |
![]() |
|||
abx060657-1mg | Abbexa | 1 mg | EUR 1873 |
![]() |
|||
Oneq-H731-100R | Bioingentech | 100T | EUR 1610 |
![]() |
|||
Oneq-H731-150R | Bioingentech | 150T | EUR 2205 |
![]() |
|||
Oneq-H731-50R | Bioingentech | 50T | EUR 1175 |
![]() |
|||
DAG-H10295 | Creative Diagnostics | 20µg | EUR 724 |
![]() |
|||
RP-1416 | Alpha Diagnostics | 10 ug | EUR 225 |
![]() |
|||
A2063-100 | Biovision | 100 µg | EUR 318 |
![]() |
|||
A2092-50 | Biovision | 50 µg | EUR 480 |
![]() |
|||
A2093-50 | Biovision | 50 µg | EUR 480 |
![]() |
|||
E4821-100 | Biovision | 96 assays | EUR 1057 |
![]() |
|||
P1504-10 | Biovision | 10µg | EUR 156 |
![]() |
|||
P1504-50 | Biovision | 50µg | EUR 551 |
![]() |
|||
P1505-10 | Biovision | 10µg | EUR 257 |
![]() |
|||
P1554-10 | Biovision | 10 µg | EUR 176 |
![]() |
|||
P1554-50 | Biovision | 50 µg | EUR 551 |
![]() |
|||
P1533-10 | Biovision | 10 µg | Ask for price |
![]() |
|||
P1533-50 | Biovision | 50 µg | Ask for price |
![]() |
|||
K075-H1R | Arbor Assays | 1-plate | EUR 552 |
Description: This K075-H1R SARS-CoV-2 IgG ELISA Kit 1-plate is only for Research Use Only (RUO), and is not to be used for diagnostic applications. |
![]() |
|||
K075-H5R | Arbor Assays | 5-plate | EUR 2054 |
Description: This K075-H5R SARS-CoV-2 IgG ELISA Kit 5-plate is only for Research Use Only (RUO), and is not to be used for diagnostic applications. |
![]() |
|||
QP11489-100ug | EnQuireBio | 100ug | EUR 218 |
![]() |
|||
QP11489-1mg | EnQuireBio | 1mg | EUR 1061 |
![]() |
|||
QP11489-500ug | EnQuireBio | 500ug | EUR 663 |
![]() |
|||
QP11490-100ug | EnQuireBio | 100ug | EUR 218 |
![]() |
|||
QP11490-1mg | EnQuireBio | 1mg | EUR 1261 |
![]() |
|||
QP11490-500ug | EnQuireBio | 500ug | EUR 663 |
![]() |
|||
QP13423-1mg | EnQuireBio | 1mg | EUR 3954 |
![]() |
|||
QP13423-20ug | EnQuireBio | 20ug | EUR 201 |
![]() |
|||
QP13423-5ug | EnQuireBio | 5ug | EUR 155 |
![]() |
|||
VAng-Wyb8617-inquire | Creative Biolabs | inquire | Ask for price |
Description: SARS-CoV Nucleocapsid (aa 1-49), recombinant protein from E. coli, 1 mg/mL. |
![]() |
|||
VAng-Wyb8619-inquire | Creative Biolabs | inquire | Ask for price |
Description: SARS-CoV Nucleocapsid (aa 340-390), recombinant protein from E. coli, 1 mg/mL. |
![]() |
|||
VAng-Wyb8620-inquire | Creative Biolabs | inquire | Ask for price |
Description: SARS-CoV C-terminal of the Spike protein (37 kDa), recombinant protein from E. coli, 1 mg/mL. |
![]() |
|||
VAng-Wyb8621-inquire | Creative Biolabs | inquire | Ask for price |
Description: SARS-CoV middle region of the Spike protein (38 kDa), recombinant protein from E. coli, 1 mg/mL. |
![]() |
|||
DAG-H10297 | Creative Diagnostics | 20µg | EUR 724 |
![]() |
|||
DAG-H10300 | Creative Diagnostics | 20µg | EUR 724 |
![]() |
|||
DAG-H10302 | Creative Diagnostics | 20µg | EUR 724 |
![]() |
|||
DAGB201 | Creative Diagnostics | 20 µg | EUR 724 |
![]() |
|||
P1503-10 | Biovision | 10µg | EUR 156 |
![]() |
|||
P1503-50 | Biovision | 50µg | EUR 551 |
![]() |
|||
P1511-10 | Biovision | 10µg | EUR 156 |
![]() |
|||
P1511-50 | Biovision | 50µg | EUR 551 |
![]() |
|||
P1514-10 | Biovision | 10µg | EUR 156 |
![]() |
|||
P1514-50 | Biovision | 50µg | EUR 551 |
![]() |
|||
P1516-10 | Biovision | 10µg | EUR 257 |
![]() |
|||
P1520-10 | Biovision | 10µg | EUR 257 |